Press Resease

Chronic Disease Management Market by Disease Type (Arthritis, Cardiovascular Disease, Cancer, Diabetes, and Others), by Delivery Mode (Cloud-Based and On-Premises), by Service (Educational Services, Implementation Service, Consulting Service, and Others), and by End-User (Providers, Payers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2024

Published Date: 13-Feb-2019 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-3816 Status : Published

Global chronic disease management market expected to generate around USD 10.3 billion by 2024, at a CAGR of around 17.5% between 2019 and 2024. The growing invasion of chronic diseases along with the increasing awareness about the consequences of life-threatening diseases is estimated to drive the global chronic disease management market growth in the future.

Description

The report covers a forecast and an analysis of the chronic disease management market on a global and regional level. The study provides historical data from 2015 to 2018 along with a forecast from 2019 to 2024 based on revenue (USD Billion). The study includes drivers and restraints of the chronic disease management market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the chronic disease management market on a global and regional level.

In order to give the users of this report a comprehensive view of the chronic disease management market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Chronic Disease Management Market

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the chronic disease management market by segmenting the market based on disease type, delivery mode, service, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2024.

By disease type, the chronic disease management market is divided into arthritis, cardiovascular disease, cancer, and diabetes. By delivery mode, the chronic disease management market is bifurcated into cloud-based and on-premises. By service, the market is segmented into educational services, implementation service, consulting service, and others. The end-user segment of the chronic disease management market includes providers, payers, and others. Providers are further segmented into ambulatory care centers, hospitals, physician groups, and integrated delivery networks, diagnostic and imaging centers, home healthcare agencies, nursing homes, and assisted living facilities, and others. The payers segment is further divided into public payers and private payers.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S., Canada, Germany, France, the UK, China, Japan, India, and Brazil.

Some key players of the global chronic disease management market are TriZetto Corporation, Infosys Limited, Pegasystems Inc., Siemens Healthcare Private Limited, MINES & Associates, Inc., Allscripts Healthcare Solutions, Inc., HealthSmart Holdings, Inc., Wellcentive, Inc., EXL Healthcare, Phytel Inc., Harmony Information Systems, Inc., and ScienceSoft USA Corporation.

This report segments the global chronic disease management market into:

Global Chronic Disease Management Market: By Disease Type

  • Arthritis
  • Cardiovascular Disease
  • Cancer 
  • Diabetes
  • Others

Global Chronic Disease Management Market: By Delivery Mode

  • Cloud-Based
  • On-Premises

Global Chronic Disease Management Market: By Service

  • Educational Implementation Service
  • Implementation Service
  • Consulting Service
  • Others

Global Chronic Disease Management Market: By End-User

  • Providers
    • Ambulatory Care Centers
    • Hospitals, Physician Groups, and Integrated Delivery Networks
    • Diagnostic and Imaging Centers
    • Home Healthcare Agencies, Nursing Homes, and Assisted Living Facilities
    • Others
  • Payers
    • Public Payers
    • Private Payers 
  • Others

Global Chronic Disease Management Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global chronic disease management market, 2015 - 2024 (USD Billion)
    • 2.2. Global chronic disease management market: Snapshot
  •  
  • Chapter 3. Global Chronic Disease Management Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global chronic disease management invasion of chronic diseases
      • 3.2.2. Growing Geriatric Population
      • 3.2.3. Establishment of patient-centered mandates
    • 3.3. Market Restraints
      • 3.3.1. Global chronic disease management market restraints: Impact analysis
      • 3.3.2. Lack of trained professional for the maintenance of information
      • 3.3.3. High investments for supporting the infrastructure
      • 3.3.4. Patient reluctant to adopt chronic care solutions due to lack of awareness
    • 3.4. Opportunities
      • 3.4.1. Increasing inclinations toward patient-centric solutions
      • 3.4.2. Growing healthcare end-users offers huge potential for chronic disease management
      • 3.4.3. Increasing concern about data security
    • 3.5. Porter's Five Forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by disease type
      • 3.6.2. Market attractiveness analysis, by delivery mode
      • 3.6.3. Market attractiveness analysis, by service
      • 3.6.4. Market attractiveness analysis, by end-user
      • 3.6.5. Market attractiveness analysis, by region
  •  
  • Chapter 4. Global Chronic Disease Management Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global chronic disease management market: company market share, 2015
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research and Development and Regional Expansion
  •  
  • Chapter 5. Global Chronic Disease Management Market - Disease Type Analysis
    • 5.1. Global chronic disease management market: disease type overview
      • 5.1.1. Global chronic disease management market revenue share, by disease type, 2018 and 2024
    • 5.2. Arthritis
      • 5.2.1. Global chronic disease management market for arthritis, 2015 - 2024 (USD Billion)
    • 5.3. Cardiovascular Disease
      • 5.3.1. Global chronic disease management market for cardiovascular disease, 2015 - 2024 (USD Billion)
    • 5.4. Cancer
      • 5.4.1. Global chronic disease management market for cancer, 2015 - 2024 (USD Billion)
    • 5.5. Diabetes
      • 5.5.1. Global chronic disease management market for diabetes, 2015 - 2024 (USD Billion)
    • 5.6. Others
      • 5.6.1. Global chronic disease management market for others, 2015 - 2024 (USD Billion)
  •  
  • Chapter 6. Global Chronic Disease Management Market - Delivery Mode Analysis
    • 6.1. Global chronic disease management market: delivery mode overview
      • 6.1.1. Global chronic disease management market revenue share, by delivery mode, 2018 and 2024
    • 6.2. Cloud-Based
      • 6.2.1. Global chronic disease management market for cloud-based, 2015 - 2024 (USD Billion)
    • 6.3. On-Premises
      • 6.3.1. Global chronic disease management market for on-premises, 2015 - 2024 (USD Billion)
  •  
  • Chapter 7. Global Chronic Disease Management Market - Service Analysis
    • 7.1. Global chronic disease management market: Service overview
      • 7.1.1. Global chronic disease management market revenue share, by Service, 2018 and 2024
    • 7.2. Educational Implementation Service
      • 7.2.1. Global chronic disease management market for Educational Implementation Service, 2015 - 2024 (USD Billion)
    • 7.3. Implementation Service
      • 7.3.1. Global chronic disease management market for Implementation Service, 2015 - 2024 (USD Billion)
    • 7.4. Consulting service
      • 7.4.1. Global chronic disease management market for Consulting Service, 2015 - 2024 (USD Billion)
    • 7.5. Others
      • 7.5.1. Global chronic disease management market for Others, 2015 - 2024 (USD Billion)
  •  
  • Chapter 8. Global Chronic Disease Management Market - End-User Analysis
    • 8.1. Global chronic disease management market: End-User overview
      • 8.1.1. Global chronic disease management market revenue share, by End-User, 2018 and 2024
    • 8.2. Providers
      • 8.2.1. Global chronic disease management market for providers, 2015 - 2024 (USD Billion)
    • 8.3. Payers
      • 8.3.1. Global chronic disease management market for payers, 2015 - 2024 (USD Billion)
    • 8.4. Others
      • 8.4.1. Global chronic disease management market for others, 2015 - 2024 (USD Billion)
  •  
  • Chapter 9. Global Chronic Disease Management Market - Regional Analysis
    • 9.1. Global chronic disease management market: regional overview
      • 9.1.1. Global chronic disease management market revenue share, by region, 2018 and 2024
      • 9.1.2. North America
        • 9.1.2.1. North America chronic disease management market revenue, by disease type, 2015 - 2024 (USD Billion)
        • 9.1.2.2. North America chronic disease management market revenue, by delivery mode, 2015 - 2024 (USD Billion)
        • 9.1.2.3. North America chronic disease management market revenue, by service, 2015 - 2024 (USD Billion)
        • 9.1.2.4. North America chronic disease management market revenue, by End-User, 2015 - 2024 (USD Billion)
      • 9.1.3. The U.S.
        • 9.1.3.1. The U.S. chronic disease management market revenue, by disease type, 2015 - 2024 (USD Billion)
        • 9.1.3.2. The U.S. chronic disease management market revenue, by delivery mode, 2015 - 2024 (USD Billion)
        • 9.1.3.3. The U.S. chronic disease management market revenue, by service, 2015 - 2024 (USD Billion)
        • 9.1.3.4. The U.S. chronic disease management market revenue, by End-User, 2015 - 2024 (USD Billion)
      • 9.1.4. Canada
        • 9.1.4.1. Canada chronic disease management market revenue, by disease type, 2015 - 2024 (USD Billion)
        • 9.1.4.2. Canada chronic disease management market revenue, by delivery mode, 2015 - 2024 (USD Billion)
        • 9.1.4.3. Canada chronic disease management market revenue, by service, 2015 - 2024 (USD Billion)
        • 9.1.4.4. Canada chronic disease management market revenue, by End-User, 2015 - 2024 (USD Billion)
    • 9.2. Europe
      • 9.2.1. Europe chronic disease management market revenue, by disease type, 2015 - 2024 (USD Billion)
      • 9.2.2. Europe chronic disease management market revenue, by delivery mode, 2015 - 2024 (USD Billion)
      • 9.2.3. Europe chronic disease management market revenue, by service, 2015 - 2024 (USD Billion)
      • 9.2.4. Europe chronic disease management market revenue, by End-User, 2015 - 2024 (USD Billion)
      • 9.2.5. UK
        • 9.2.5.1. UK chronic disease management market revenue, by disease type, 2015 - 2024 (USD Billion)
        • 9.2.5.2. UK chronic disease management market revenue, by delivery mode, 2015 - 2024 (USD Billion)
        • 9.2.5.3. UK chronic disease management market revenue, by service, 2015 - 2024 (USD Billion)
        • 9.2.5.4. UK chronic disease management market revenue, by End-User, 2015 - 2024 (USD Billion)
      • 9.2.6. Germany
        • 9.2.6.1. Germany chronic disease management market revenue, by disease type, 2015 - 2024 (USD Billion)
        • 9.2.6.2. Germany chronic disease management market revenue, by delivery mode, 2015 - 2024 (USD Billion)
        • 9.2.6.3. Germany chronic disease management market revenue, by service, 2015 - 2024 (USD Billion)
        • 9.2.6.4. Germany chronic disease management market revenue, by End-User, 2015 - 2024 (USD Billion)
      • 9.2.7. France
        • 9.2.7.1. France chronic disease management market revenue, by disease type, 2015 - 2024 (USD Billion)
        • 9.2.7.2. France chronic disease management market revenue, by delivery mode, 2015 - 2024 (USD Billion)
        • 9.2.7.3. France chronic disease management market revenue, by service, 2015 - 2024 (USD Billion)
        • 9.2.7.4. France chronic disease management market revenue, by End-User, 2015 - 2024 (USD Billion)
      • 9.2.8. Rest of Europe
        • 9.2.8.1. Rest of Europe chronic disease management market revenue, by disease type, 2015 - 2024 (USD Billion)
        • 9.2.8.2. Rest of Europe chronic disease management market revenue, by delivery mode, 2015 - 2024 (USD Billion)
        • 9.2.8.3. Rest of Europe chronic disease management market revenue, by service, 2015 - 2024 (USD Billion)
        • 9.2.8.4. Rest of Europe chronic disease management market revenue, by End-User, 2015 - 2024 (USD Billion)
    • 9.3. Asia Pacific
      • 9.3.1. Asia Pacific chronic disease management market revenue, by disease type, 2015 - 2024 (USD Billion)
      • 9.3.2. Asia Pacific chronic disease management market revenue, by delivery mode, 2015 - 2024 (USD Billion)
      • 9.3.3. Asia Pacific chronic disease management market revenue, by service, 2015 - 2024 (USD Billion)
      • 9.3.4. Asia Pacific chronic disease management market revenue, by End-User, 2015 - 2024 (USD Billion)
      • 9.3.5. China
        • 9.3.5.1. China chronic disease management market revenue, by disease type, 2015 - 2024 (USD Billion)
        • 9.3.5.2. China chronic disease management market revenue, by delivery mode, 2015 - 2024 (USD Billion)
        • 9.3.5.3. China chronic disease management market revenue, by service, 2015 - 2024 (USD Billion)
        • 9.3.5.4. China chronic disease management market revenue, by End-User, 2015 - 2024 (USD Billion)
      • 9.3.6. Japan
        • 9.3.6.1. Japan chronic disease management market revenue, by disease type, 2015 - 2024 (USD Billion)
        • 9.3.6.2. Japan chronic disease management market revenue, by delivery mode, 2015 - 2024 (USD Billion)
        • 9.3.6.3. Japan chronic disease management market revenue, by service, 2015 - 2024 (USD Billion)
        • 9.3.6.4. Japan chronic disease management market revenue, by End-User, 2015 - 2024 (USD Billion)
      • 9.3.7. India
        • 9.3.7.1. India chronic disease management market revenue, by disease type, 2015 - 2024 (USD Billion)
        • 9.3.7.2. India chronic disease management market revenue, by delivery mode, 2015 - 2024 (USD Billion)
        • 9.3.7.3. India chronic disease management market revenue, by service, 2015 - 2024 (USD Billion)
        • 9.3.7.4. India chronic disease management market revenue, by End-User, 2015 - 2024 (USD Billion)
      • 9.3.8. Rest of Asia Pacific
        • 9.3.8.1. Rest of Asia Pacific chronic disease management market revenue, by disease type, 2015 - 2024 (USD Billion)
        • 9.3.8.2. Rest of Asia Pacific chronic disease management market revenue, by delivery mode, 2015 - 2024 (USD Billion)
        • 9.3.8.3. Rest of Asia Pacific chronic disease management market revenue, by service, 2015 - 2024 (USD Billion)
        • 9.3.8.4. Rest of Asia Pacific chronic disease management market revenue, by End-User, 2015 - 2024 (USD Billion)
    • 9.4. Latin America
      • 9.4.1. Latin America chronic disease management market revenue, by disease type, 2015 - 2024(USD Billion)
      • 9.4.2. Latin America chronic disease management market revenue, by delivery mode, 2015 - 2024 (USD Billion)
      • 9.4.3. Latin America chronic disease management market revenue, by service, 2015 - 2024 (USD Billion)
      • 9.4.4. Latin America chronic disease management market revenue, by End-User, 2015 - 2024(USD Billion)
      • 9.4.5. Brazil
        • 9.4.5.1. Brazil chronic disease management market revenue, by disease type, 2015 - 2024 (USD Billion)
        • 9.4.5.2. Brazil chronic disease management market revenue, by delivery mode, 2015 - 2024 (USD Billion)
        • 9.4.5.3. Brazil chronic disease management market revenue, by service, 2015 - 2024 (USD Billion)
        • 9.4.5.4. Brazil chronic disease management market revenue, by End-User, 2015 - 2024 (USD Billion)
      • 9.4.6. Rest of Latin America
        • 9.4.6.1. Rest of Latin America chronic disease management market revenue, by disease type, 2015 - 2024 (USD Billion)
        • 9.4.6.2. Rest of Latin America chronic disease management market revenue, by delivery mode, 2015 - 2024 (USD Billion)
        • 9.4.6.3. Rest of Latin America chronic disease management market revenue, by service, 2015 - 2024 (USD Billion)
        • 9.4.6.4. Rest of Latin America chronic disease management market revenue, by End-User, 2015 - 2024 (USD Billion)
    • 9.5. The Middle East and Africa
      • 9.5.1. The Middle East and Africa chronic disease management market revenue, by disease type, 2015 - 2024 (USD Billion)
      • 9.5.2. The Middle East and Africa chronic disease management market revenue, by delivery mode, 2015 - 2024 (USD Billion)
      • 9.5.3. The Middle East and Africa chronic disease management market revenue, by service, 2015 - 2024 (USD Billion)
      • 9.5.4. The Middle East and Africa chronic disease management market revenue, by End-User, 2015 - 2024 (USD Billion)
  •  
  • Chapter 10. Company Profile
    • 10.1. TriZetto Corporation
      • 10.1.1. Overview
      • 10.1.2. Financials
      • 10.1.3. Product portfolio
      • 10.1.4. Business strategy
      • 10.1.5. Recent developments
    • 10.2. Infosys Limited
      • 10.2.1. Overview
      • 10.2.2. Financials
      • 10.2.3. Product portfolio
      • 10.2.4. Business strategy
      • 10.2.5. Recent developments
    • 10.3. Pegasystems Inc.
      • 10.3.1. Overview
      • 10.3.2. Financials
      • 10.3.3. Product portfolio
      • 10.3.4. Business strategy
      • 10.3.5. Recent developments
    • 10.4. Siemens Healthcare Private Limited
      • 10.4.1. Overview
      • 10.4.2. Financials
      • 10.4.3. Product portfolio
      • 10.4.4. Business strategy
      • 10.4.5. Recent developments
    • 10.5. MINES & Associates, Inc.
      • 10.5.1. Overview
      • 10.5.2. Financials
      • 10.5.3. Product portfolio
      • 10.5.4. Business strategy
      • 10.5.5. Recent developments
    • 10.6. Allscripts Healthcare Solutions, Inc.
      • 10.6.1. Overview
      • 10.6.2. Financials
      • 10.6.3. Product portfolio
      • 10.6.4. Business strategy
      • 10.6.5. Recent developments
    • 10.7. HealthSmart Holdings, Inc.
      • 10.7.1. Overview
      • 10.7.2. Financials
      • 10.7.3. Product portfolio
      • 10.7.4. Business strategy
      • 10.7.5. Recent developments
    • 10.8. Wellcentive, Inc.
      • 10.8.1. Overview
      • 10.8.2. Financials
      • 10.8.3. Product portfolio
      • 10.8.4. Business strategy
      • 10.8.5. Recent developments
    • 10.9. EXL Healthcare
      • 10.9.1. Overview
      • 10.9.2. Financials
      • 10.9.3. Product portfolio
      • 10.9.4. Business strategy
      • 10.9.5. Recent developments
    • 10.10. Phytel Inc.
      • 10.10.1. Overview
      • 10.10.2. Financials
      • 10.10.3. Product portfolio
      • 10.10.4. Business strategy
      • 10.10.5. Recent developments
    • 10.11. Harmony Information Systems, Inc.
      • 10.11.1. Overview
      • 10.11.2. Financials
      • 10.11.3. Product portfolio
      • 10.11.4. Business strategy
      • 10.11.5. Recent developments
    • 10.12. ScienceSoft USA Corporation
      • 10.12.1. Overview
      • 10.12.2. Financials
      • 10.12.3. Product portfolio
      • 10.12.4. Business strategy
      • 10.12.5. Recent developments

Methodology

Free Analysis

Chronic diseases are medical conditions that develop over a period. Chronic disease management is an organized set of innervations used by healthcare payers and providers to provide long-term effective care solutions. Chronic disease management uses healthcare-based integrated web solutions to provide patient-centric, cost-effective, and efficient management solutions.

The increasing number of people suffering from a variety of chronic diseases, such as arthritis, cardiovascular disorders, cancer, diabetes, obesity, and others has created huge growth potential for the expansion of the chronic disease management market globally in the future. The presence of a large patient pool and the growing need to develop a strong healthcare management platform are other factors estimated to drive the chronic disease management market growth over the estimated time period on a global scale.

Global Chronic Disease Management Market

The global chronic disease management market is segmented based on disease type, delivery mode, service, and end-user. By disease type, the chronic disease management market is divided into arthritis, cardiovascular disease, cancer, and diabetes. By delivery mode, the market is bifurcated into cloud-based and on-premises. By service, the market is segmented into educational services, implementation service, consulting service, and others. The end-user segment of the chronic disease management market includes providers, payers, and others. Providers are further segmented into ambulatory care centers, hospitals, physician groups, and integrated delivery networks, diagnostic and imaging centers, home healthcare agencies, nursing homes, and assisted living facilities, and others. The payers segment is further divided into public payers and private payers.

By region, North America is anticipated to dominate the chronic disease management market globally over the forecast time period. This can be attributed to the favorable government policies supporting the introduction of new and advanced services, substantial developments witnessed in the healthcare infrastructure, and funds for research granted by the government and ruling authorities. The Asia Pacific is anticipated to demonstrate the fastest growth rate over the forecast timeframe, owing to the region’s thriving healthcare industry due to a large population base, especially in India, China, and Japan. The Latin American market is estimated to grow at a moderate rate over the projected time period. The Middle East and African market is expected to contribute a prominent share to the global chronic disease management market in the upcoming years.

Some key players of the global chronic disease management market are TriZetto Corporation, Infosys Limited, Pegasystems Inc., Siemens Healthcare Private Limited, MINES & Associates, Inc., Allscripts Healthcare Solutions, Inc., HealthSmart Holdings, Inc., Wellcentive, Inc., EXL Healthcare, Phytel Inc., Harmony Information Systems, Inc., and ScienceSoft USA Corporation.

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com